In this study, we found that circPLCE1 encoded a novel protein to inhibit NF-κB activity to suppress CRC progression, which may enable circPLCE1 as a novel and potentially valuable RNA therapeutic target for CRC patients. This evidence concerns the gene NFKB1 and colorectal carcinoma.